James S. Ely III Sells 9,000 Shares of Select Medical Holdings Co. (NYSE:SEM) Stock

Select Medical Holdings Co. (NYSE:SEM) Director James S. Ely III sold 9,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 6th. The shares were sold at an average price of $20.00, for a total value of $180,000.00. Following the completion of the sale, the director now owns 101,865 shares in the company, valued at approximately $2,037,300. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

NYSE SEM traded down $0.05 on Monday, reaching $19.33. The stock had a trading volume of 405,400 shares, compared to its average volume of 615,684. The company has a debt-to-equity ratio of 3.72, a current ratio of 1.49 and a quick ratio of 1.49. Select Medical Holdings Co. has a 1-year low of $15.83 and a 1-year high of $21.65. The firm has a market cap of $2.62 billion, a price-to-earnings ratio of 19.93, a P/E/G ratio of 1.32 and a beta of 1.42.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, November 1st. The health services provider reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.28 billion. Select Medical had a return on equity of 15.95% and a net margin of 4.32%. The company’s revenue for the quarter was up 17.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.14 EPS. On average, equities analysts anticipate that Select Medical Holdings Co. will post 1.05 earnings per share for the current fiscal year.

Several equities research analysts have commented on the company. Credit Suisse Group boosted their target price on Select Medical from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, November 5th. ValuEngine raised Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, November 2nd. Finally, Zacks Investment Research raised Select Medical from a “sell” rating to a “hold” rating in a research report on Thursday, October 4th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $20.83.

Several hedge funds have recently made changes to their positions in the stock. BlackRock Inc. lifted its position in shares of Select Medical by 6.0% during the 3rd quarter. BlackRock Inc. now owns 16,163,430 shares of the health services provider’s stock worth $297,407,000 after buying an additional 919,508 shares during the last quarter. Vanguard Group Inc. raised its position in Select Medical by 0.7% in the third quarter. Vanguard Group Inc. now owns 10,514,877 shares of the health services provider’s stock valued at $193,473,000 after purchasing an additional 77,612 shares during the last quarter. Victory Capital Management Inc. raised its position in Select Medical by 14.8% in the third quarter. Victory Capital Management Inc. now owns 2,094,711 shares of the health services provider’s stock valued at $38,543,000 after purchasing an additional 270,498 shares during the last quarter. Point72 Asset Management L.P. raised its position in Select Medical by 251.4% in the third quarter. Point72 Asset Management L.P. now owns 1,728,700 shares of the health services provider’s stock valued at $31,808,000 after purchasing an additional 1,236,794 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in Select Medical by 8.0% in the third quarter. Bank of New York Mellon Corp now owns 1,362,793 shares of the health services provider’s stock valued at $25,076,000 after purchasing an additional 100,506 shares during the last quarter. Institutional investors and hedge funds own 75.45% of the company’s stock.

TRADEMARK VIOLATION WARNING: “James S. Ely III Sells 9,000 Shares of Select Medical Holdings Co. (NYSE:SEM) Stock” was posted by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.baseballdailydigest.com/news/2018/12/03/insider-selling-select-medical-holdings-co-sem-director-sells-180000-00-in-stock.html.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.

See Also: Technical Analysis

Insider Buying and Selling by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply